1. Главная
  2. Ресурсы
  3. Библиотечный поиск
AR‐12 InhibitsMultiple ChaperonesConcomitant WithStimulatingAutophagosomeFormationCollectivelyPreventing VirusReplication Laurence BoothJane L. RobertsHeath Ecroyd2016 год

AR‐12 Inhibits Multiple Chaperones Concomitant With Stimulating Autophagosome Formation Collectively Preventing Virus Replication
статья из журнала

Полный текстСтраница публикацииПубликация в OpenAlex
Аннотация: We have recently demonstrated that AR-12 (OSU-03012) reduces the function and ATPase activities of multiple HSP90 and HSP70 family chaperones. Combined knock down of chaperones or AR-12 treatment acted to reduce the expression of virus receptors and essential glucosidase proteins. Combined knock down of chaperones or AR-12 treatment inactivated mTOR and elevated ATG13 S318 phosphorylation concomitant with inducing an endoplasmic reticulum stress response that in an eIF2α-dependent fashion increased Beclin1 and LC3 expression and autophagosome formation. Over-expression of chaperones prevented the reduction in receptor/glucosidase expression, mTOR inactivation, the ER stress response, and autophagosome formation. AR-12 reduced the reproduction of viruses including Mumps, Influenza, Measles, Junín, Rubella, HIV (wild type and protease resistant), and Ebola, an effect replicated by knock down of multiple chaperone proteins. AR-12-stimulated the co-localization of Influenza, EBV and HIV virus proteins with LC3 in autophagosomes and reduced viral protein association with the chaperones HSP90, HSP70, and GRP78. Knock down of Beclin1 suppressed drug-induced autophagosome formation and reduced the anti-viral protection afforded by AR-12. In an animal model of hemorrhagic fever virus, a transient exposure of animals to low doses of AR-12 doubled animal survival from ∼30% to ∼60% and suppressed liver damage as measured by ATL, GGT and LDH release. Thus through inhibition of chaperone protein functions; reducing the production, stability and processing of viral proteins; and stimulating autophagosome formation/viral protein degradation, AR-12 acts as a broad-specificity anti-viral drug in vitro and in vivo. We argue future patient studies with AR-12 are warranted. J. Cell. Physiol. 231: 2286-2302, 2016. © 2016 Wiley Periodicals, Inc.
Год издания: 2016
Авторы: Laurence Booth, Jane L. Roberts, Heath Ecroyd, Sarah R. Tritsch, Sina Bavari, St. Patrick Reid, Stefan Proniuk, Alexander Zukiwski, Abraham Jacob, Claudia S. Sepúlveda, Federico Giovannoni, Cybele C. Garcı́a, Elsa B. Damonte, Javier González‐Gallego, María J. Tuñón, Paul Dent
Издательство: Wiley
Источник: Journal of Cellular Physiology
Ключевые слова: Viral Infections and Outbreaks Research, Viral Infections and Vectors, Hepatitis B Virus Studies
Другие ссылки: Journal of Cellular Physiology (HTML)
CONICET Digital (CONICET) (PDF)
CONICET Digital (CONICET) (HTML)
Europe PMC (PubMed Central) (PDF)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
PubMed (HTML)